Quick Takeaways
- Charles Cherington filed SCHEDULE 13D/A for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
- Disclosed ownership: 33%.
- Date of event: 02 Apr 2025.
Charles Cherington - 02 Apr 2025 SCHEDULE 13D/A Report for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
- Filing Manager
- Charles Cherington
- Reporting Manager
- Charles Cherington
- Symbol
- ERNA
- Shares outstanding
- 62,294,616 shares
- Disclosed Ownership
- 20,432,634 shares
- Ownership
- 33%
- Form type
- SCHEDULE 13D/A
- Filing time
- 04 Apr 2025, 10:55:59 UTC
- Date of event
- 02 Apr 2025
- Previous filing
- 05 Mar 2025
- Next filing
- 11 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Charles Cherington disclosed 33% ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA) on 02 Apr 2025."
What Changed
- Previous schedule filing date: 05 Mar 2025.
- Current filing was accepted on 04 Apr 2025, 10:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Charles Cherington | 33% | 20,432,634 | 20,432,634 | 0 | /s/ Charles Cherington | Charles Cherington | 0001448698 |